

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement (GO:0003351) | 9.80956353 |
| 2 | skeletal muscle adaptation (GO:0043501) | 9.41839120 |
| 3 | skeletal muscle fiber development (GO:0048741) | 8.34323707 |
| 4 | actin filament-based movement (GO:0030048) | 7.86368666 |
| 5 | plasma membrane repair (GO:0001778) | 7.52506528 |
| 6 | axoneme assembly (GO:0035082) | 7.43571440 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.27291850 |
| 8 | myotube cell development (GO:0014904) | 7.13713047 |
| 9 | primary alcohol catabolic process (GO:0034310) | 7.00913713 |
| 10 | striated muscle contraction (GO:0006941) | 6.92452999 |
| 11 | sarcomere organization (GO:0045214) | 6.92061466 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.89489197 |
| 13 | left/right pattern formation (GO:0060972) | 6.66275083 |
| 14 | glycogen catabolic process (GO:0005980) | 6.25110517 |
| 15 | striated muscle atrophy (GO:0014891) | 6.20046370 |
| 16 | myofibril assembly (GO:0030239) | 6.18083266 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.98271815 |
| 18 | response to inactivity (GO:0014854) | 5.97860043 |
| 19 | skeletal muscle tissue regeneration (GO:0043403) | 5.96900398 |
| 20 | carnitine shuttle (GO:0006853) | 5.84994357 |
| 21 | glucan catabolic process (GO:0009251) | 5.83978176 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.80622441 |
| 23 | response to muscle activity (GO:0014850) | 5.76358720 |
| 24 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.73616691 |
| 25 | regulation of cilium movement (GO:0003352) | 5.70793136 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.68661934 |
| 27 | creatine metabolic process (GO:0006600) | 5.67834012 |
| 28 | muscle contraction (GO:0006936) | 5.63130743 |
| 29 | purine nucleotide salvage (GO:0032261) | 5.56248510 |
| 30 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.48832589 |
| 31 | cellular polysaccharide catabolic process (GO:0044247) | 5.48206110 |
| 32 | ethanol metabolic process (GO:0006067) | 5.46181320 |
| 33 | striated muscle adaptation (GO:0014888) | 5.43183952 |
| 34 | cytidine deamination (GO:0009972) | 5.43100027 |
| 35 | cytidine metabolic process (GO:0046087) | 5.43100027 |
| 36 | cytidine catabolic process (GO:0006216) | 5.43100027 |
| 37 | IMP metabolic process (GO:0046040) | 5.42625403 |
| 38 | vitamin transmembrane transport (GO:0035461) | 5.40976837 |
| 39 | muscle atrophy (GO:0014889) | 5.33620417 |
| 40 | polysaccharide catabolic process (GO:0000272) | 5.18952543 |
| 41 | muscle fiber development (GO:0048747) | 5.16672733 |
| 42 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.10846400 |
| 43 | muscle system process (GO:0003012) | 5.00249783 |
| 44 | microtubule bundle formation (GO:0001578) | 4.96424448 |
| 45 | glycogen biosynthetic process (GO:0005978) | 4.92821415 |
| 46 | glucan biosynthetic process (GO:0009250) | 4.92821415 |
| 47 | diterpenoid biosynthetic process (GO:0016102) | 4.87854950 |
| 48 | actomyosin structure organization (GO:0031032) | 4.86933316 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 4.84698278 |
| 50 | left/right axis specification (GO:0070986) | 4.75296409 |
| 51 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.69634888 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.66456435 |
| 53 | ventricular system development (GO:0021591) | 4.52905408 |
| 54 | IMP biosynthetic process (GO:0006188) | 4.39743103 |
| 55 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.37523340 |
| 56 | muscle adaptation (GO:0043500) | 4.35594319 |
| 57 | cytoplasmic microtubule organization (GO:0031122) | 4.35394395 |
| 58 | ethanol oxidation (GO:0006069) | 4.32776432 |
| 59 | regulation of cofactor metabolic process (GO:0051193) | 4.32270040 |
| 60 | regulation of coenzyme metabolic process (GO:0051196) | 4.32270040 |
| 61 | response to xenobiotic stimulus (GO:0009410) | 4.30541759 |
| 62 | intraciliary transport (GO:0042073) | 4.29661693 |
| 63 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.28353058 |
| 64 | glycogen metabolic process (GO:0005977) | 4.26781129 |
| 65 | cardiac muscle contraction (GO:0060048) | 4.22719788 |
| 66 | lung epithelium development (GO:0060428) | 4.22666822 |
| 67 | carnitine transmembrane transport (GO:1902603) | 4.22448308 |
| 68 | one-carbon compound transport (GO:0019755) | 4.19788352 |
| 69 | muscle cell cellular homeostasis (GO:0046716) | 4.19174875 |
| 70 | cellular glucan metabolic process (GO:0006073) | 4.17836122 |
| 71 | glucan metabolic process (GO:0044042) | 4.17836122 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 4.13006606 |
| 73 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.09294025 |
| 74 | negative regulation of muscle hypertrophy (GO:0014741) | 4.07631729 |
| 75 | positive regulation of myoblast differentiation (GO:0045663) | 4.06860205 |
| 76 | muscle organ development (GO:0007517) | 4.03692673 |
| 77 | striated muscle cell development (GO:0055002) | 4.03169580 |
| 78 | myotube differentiation (GO:0014902) | 4.00926013 |
| 79 | neuronal action potential propagation (GO:0019227) | 3.99276747 |
| 80 | muscle structure development (GO:0061061) | 3.96986618 |
| 81 | tricarboxylic acid cycle (GO:0006099) | 3.95311893 |
| 82 | sperm capacitation (GO:0048240) | 3.93299772 |
| 83 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.93221149 |
| 84 | muscle organ morphogenesis (GO:0048644) | 3.90199575 |
| 85 | positive regulation of myotube differentiation (GO:0010831) | 3.89716188 |
| 86 | cilium organization (GO:0044782) | 3.89221707 |
| 87 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.88123130 |
| 88 | establishment of apical/basal cell polarity (GO:0035089) | 3.85325649 |
| 89 | amino-acid betaine transport (GO:0015838) | 3.83302043 |
| 90 | carnitine transport (GO:0015879) | 3.83302043 |
| 91 | tolerance induction (GO:0002507) | 3.81952255 |
| 92 | response to activity (GO:0014823) | 3.81567058 |
| 93 | regulation of germinal center formation (GO:0002634) | 3.78620049 |
| 94 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.78229480 |
| 95 | cilium assembly (GO:0042384) | 3.77657380 |
| 96 | cardiac myofibril assembly (GO:0055003) | 3.77649791 |
| 97 | regulation of relaxation of muscle (GO:1901077) | 3.77074847 |
| 98 | skeletal muscle tissue development (GO:0007519) | 3.72871283 |
| 99 | negative regulation of B cell mediated immunity (GO:0002713) | 3.70101004 |
| 100 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.70101004 |
| 101 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.70018954 |
| 102 | glomerular epithelial cell development (GO:0072310) | 3.59681256 |
| 103 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.57172616 |
| 104 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.56437337 |
| 105 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.55686619 |
| 106 | heart process (GO:0003015) | 3.55306742 |
| 107 | heart contraction (GO:0060047) | 3.55306742 |
| 108 | negative regulation of inclusion body assembly (GO:0090084) | 3.55008295 |
| 109 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.52465694 |
| 110 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.52465694 |
| 111 | myoblast fusion (GO:0007520) | 3.52180635 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.51253511 |
| 113 | retinoic acid metabolic process (GO:0042573) | 3.50573428 |
| 114 | muscle cell development (GO:0055001) | 3.45702585 |
| 115 | regulation of sulfur metabolic process (GO:0042762) | 3.44027053 |
| 116 | regulation of striated muscle contraction (GO:0006942) | 3.43943395 |
| 117 | regulation of microtubule-based movement (GO:0060632) | 3.42966421 |
| 118 | cellular carbohydrate catabolic process (GO:0044275) | 3.42826004 |
| 119 | cellular response to dexamethasone stimulus (GO:0071549) | 3.39626203 |
| 120 | establishment of monopolar cell polarity (GO:0061162) | 3.35892591 |
| 121 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.35892591 |
| 122 | cardiac muscle cell development (GO:0055013) | 3.34738871 |
| 123 | muscle cell fate commitment (GO:0042693) | 3.30305886 |
| 124 | terpenoid biosynthetic process (GO:0016114) | 3.28327115 |
| 125 | regulation of actin filament-based movement (GO:1903115) | 3.27610563 |
| 126 | regulation of interleukin-5 production (GO:0032674) | 3.25560440 |
| 127 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.24783322 |
| 128 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.22822965 |
| 129 | neuromuscular junction development (GO:0007528) | 3.22664105 |
| 130 | syncytium formation (GO:0006949) | 3.20788759 |
| 131 | microtubule-based movement (GO:0007018) | 3.20456985 |
| 132 | regulation of myoblast differentiation (GO:0045661) | 3.19778100 |
| 133 | centriole assembly (GO:0098534) | 3.17141979 |
| 134 | response to dexamethasone (GO:0071548) | 3.13928338 |
| 135 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.09750504 |
| 136 | regulation of microtubule depolymerization (GO:0031114) | 3.09430588 |
| 137 | positive regulation of tolerance induction (GO:0002645) | 3.09410297 |
| 138 | negative regulation of humoral immune response (GO:0002921) | 3.03982225 |
| 139 | protein localization to cilium (GO:0061512) | 2.92555073 |
| 140 | carnitine metabolic process (GO:0009437) | 2.92072348 |
| 141 | regulation of response to osmotic stress (GO:0047484) | 2.85488523 |
| 142 | cell projection assembly (GO:0030031) | 2.85418614 |
| 143 | regulation of interleukin-13 production (GO:0032656) | 2.84473096 |
| 144 | negative regulation of microtubule depolymerization (GO:0007026) | 2.76508269 |
| 145 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.75512968 |
| 146 | axonemal dynein complex assembly (GO:0070286) | 16.6759714 |
| 147 | cilium or flagellum-dependent cell motility (GO:0001539) | 13.0534384 |
| 148 | muscle filament sliding (GO:0030049) | 12.9284094 |
| 149 | actin-myosin filament sliding (GO:0033275) | 12.9284094 |
| 150 | regulation of skeletal muscle contraction (GO:0014819) | 11.7810524 |
| 151 | skeletal muscle contraction (GO:0003009) | 11.4854567 |
| 152 | motile cilium assembly (GO:0044458) | 11.3767937 |
| 153 | cilium movement (GO:0003341) | 11.2453249 |
| 154 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 10.7177790 |
| 155 | actin-mediated cell contraction (GO:0070252) | 10.5832931 |
| 156 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.2384993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.88127436 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.44658911 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.12915865 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.83964224 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.70350991 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.47740213 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.34604782 |
| 8 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 3.10007610 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.07740883 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.91969676 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.66211373 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.66211373 |
| 13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.42845641 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.41646592 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34803671 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.21300903 |
| 17 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.19364097 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.05535577 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.02848152 |
| 20 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.98028149 |
| 21 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.97196970 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96423374 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84515303 |
| 24 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.84035304 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.81627179 |
| 26 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.76400918 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73187273 |
| 28 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.72333926 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.66310308 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63997084 |
| 31 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.63952430 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.62436543 |
| 33 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.58901699 |
| 34 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.57670215 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57314946 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57231054 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.53875130 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.53130902 |
| 39 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51076981 |
| 40 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48716050 |
| 41 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.47387537 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46083277 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44973032 |
| 44 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.43634473 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43138829 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41066182 |
| 47 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.40049918 |
| 48 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.38831427 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37281726 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37273305 |
| 51 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37020205 |
| 52 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.35907468 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35023474 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32365230 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30832957 |
| 56 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30608926 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30164068 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28949133 |
| 59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28004194 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27943298 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25325849 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22846550 |
| 63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.21984922 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21950732 |
| 65 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.20469213 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19765541 |
| 67 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.19716442 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19379909 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18982274 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18469836 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.18416164 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17503730 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16121045 |
| 74 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15616945 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15347760 |
| 76 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14862899 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14694639 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14013126 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13612581 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13142547 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12887891 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12506472 |
| 83 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10858019 |
| 84 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08965493 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08026756 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07741505 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07386078 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07334789 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06701753 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06196842 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05755013 |
| 92 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04848941 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04422973 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.03334237 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03311327 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03016605 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02507700 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01842207 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01469517 |
| 100 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.01282047 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01012995 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00393233 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00193049 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00193049 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99404525 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98837659 |
| 107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98833850 |
| 108 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98793559 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98514563 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98352886 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98333100 |
| 112 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98332930 |
| 113 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98281929 |
| 114 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.95645868 |
| 115 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95397985 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95150561 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94713776 |
| 118 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.93564010 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93526406 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92593513 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92412394 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92226167 |
| 123 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91964067 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91399862 |
| 125 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91339001 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91158108 |
| 127 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89548213 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89270953 |
| 129 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89001743 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.87844648 |
| 131 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87164253 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86549287 |
| 133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86405370 |
| 134 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86165305 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.86093024 |
| 136 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85696883 |
| 137 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85230867 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84973352 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84728712 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84489561 |
| 141 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.84136651 |
| 142 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84011526 |
| 143 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83665059 |
| 144 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.83524734 |
| 145 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83425068 |
| 146 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83409859 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82827934 |
| 148 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.82485622 |
| 149 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82239242 |
| 150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81424667 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81399084 |
| 152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78174528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.03026221 |
| 2 | MP0000749_muscle_degeneration | 6.37815729 |
| 3 | MP0003646_muscle_fatigue | 6.12507132 |
| 4 | MP0000751_myopathy | 5.65364508 |
| 5 | MP0000747_muscle_weakness | 4.40258701 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.27446167 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.10537874 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89306361 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.86110981 |
| 10 | MP0002269_muscular_atrophy | 3.68923814 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.65865483 |
| 12 | MP0005369_muscle_phenotype | 3.53123705 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.50594675 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.50263362 |
| 15 | MP0002653_abnormal_ependyma_morphology | 3.16238038 |
| 16 | MP0004130_abnormal_muscle_cell | 3.14782483 |
| 17 | MP0005620_abnormal_muscle_contractility | 3.14208153 |
| 18 | MP0002132_abnormal_respiratory_system | 3.06940856 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.91755241 |
| 20 | MP0004233_abnormal_muscle_weight | 2.85156382 |
| 21 | MP0005451_abnormal_body_composition | 2.83514435 |
| 22 | MP0000733_abnormal_muscle_development | 2.52956326 |
| 23 | MP0002332_abnormal_exercise_endurance | 2.28165526 |
| 24 | MP0005330_cardiomyopathy | 2.11799810 |
| 25 | MP0004084_abnormal_cardiac_muscle | 2.08877882 |
| 26 | MP0002108_abnormal_muscle_morphology | 1.98103210 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.93621976 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.87748606 |
| 29 | MP0001984_abnormal_olfaction | 1.86511184 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.83356762 |
| 31 | MP0004270_analgesia | 1.80479700 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.78114940 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.62401609 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.56724836 |
| 35 | MP0004133_heterotaxia | 1.56239887 |
| 36 | MP0002972_abnormal_cardiac_muscle | 1.39460281 |
| 37 | MP0001346_abnormal_lacrimal_gland | 1.36054969 |
| 38 | MP0010630_abnormal_cardiac_muscle | 1.33820345 |
| 39 | MP0004484_altered_response_of | 1.33653276 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.30799478 |
| 41 | MP0002971_abnormal_brown_adipose | 1.29880044 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.28898374 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.27177270 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.26953153 |
| 45 | MP0005266_abnormal_metabolism | 1.20794117 |
| 46 | MP0002822_catalepsy | 1.14268245 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.09424284 |
| 48 | MP0003137_abnormal_impulse_conducting | 1.05291902 |
| 49 | MP0001765_abnormal_ion_homeostasis | 1.01175429 |
| 50 | MP0001544_abnormal_cardiovascular_syste | 0.98900297 |
| 51 | MP0005385_cardiovascular_system_phenoty | 0.98900297 |
| 52 | MP0002168_other_aberrant_phenotype | 0.98829846 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 0.96028697 |
| 54 | MP0003878_abnormal_ear_physiology | 0.96028697 |
| 55 | MP0005165_increased_susceptibility_to | 0.95196002 |
| 56 | MP0005375_adipose_tissue_phenotype | 0.93284171 |
| 57 | MP0000678_abnormal_parathyroid_gland | 0.91087164 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.85992828 |
| 59 | MP0000383_abnormal_hair_follicle | 0.85227190 |
| 60 | MP0000372_irregular_coat_pigmentation | 0.82942907 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.82080627 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 0.80020587 |
| 63 | MP0005248_abnormal_Harderian_gland | 0.75699405 |
| 64 | MP0010678_abnormal_skin_adnexa | 0.74264779 |
| 65 | MP0004134_abnormal_chest_morphology | 0.73777915 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 0.71357352 |
| 67 | MP0002234_abnormal_pharynx_morphology | 0.70222838 |
| 68 | MP0000566_synostosis | 0.69563340 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.67625822 |
| 70 | MP0000762_abnormal_tongue_morphology | 0.65553309 |
| 71 | MP0009250_abnormal_appendicular_skeleto | 0.65036934 |
| 72 | MP0008775_abnormal_heart_ventricle | 0.64744789 |
| 73 | MP0005394_taste/olfaction_phenotype | 0.64483734 |
| 74 | MP0005499_abnormal_olfactory_system | 0.64483734 |
| 75 | MP0009379_abnormal_foot_pigmentation | 0.62980454 |
| 76 | MP0000266_abnormal_heart_morphology | 0.62685812 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.60557597 |
| 78 | MP0004043_abnormal_pH_regulation | 0.60427167 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 0.57908032 |
| 80 | MP0003879_abnormal_hair_cell | 0.55651565 |
| 81 | MP0002160_abnormal_reproductive_system | 0.54253130 |
| 82 | MP0002282_abnormal_trachea_morphology | 0.53877239 |
| 83 | MP0004147_increased_porphyrin_level | 0.53357639 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.53088782 |
| 85 | MP0006138_congestive_heart_failure | 0.52541796 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.51113932 |
| 87 | MP0005166_decreased_susceptibility_to | 0.50326602 |
| 88 | MP0005334_abnormal_fat_pad | 0.50166440 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.49799819 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.49604006 |
| 91 | MP0003828_pulmonary_edema | 0.48763731 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47758432 |
| 93 | MP0003959_abnormal_lean_body | 0.46305961 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.45583996 |
| 95 | MP0002114_abnormal_axial_skeleton | 0.45287755 |
| 96 | MP0004142_abnormal_muscle_tone | 0.44913540 |
| 97 | MP0005452_abnormal_adipose_tissue | 0.44688687 |
| 98 | MP0008569_lethality_at_weaning | 0.44386873 |
| 99 | MP0004858_abnormal_nervous_system | 0.43493669 |
| 100 | MP0009672_abnormal_birth_weight | 0.42728331 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.42123967 |
| 102 | MP0000467_abnormal_esophagus_morphology | 0.41790557 |
| 103 | MP0005670_abnormal_white_adipose | 0.40736401 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.40233313 |
| 105 | MP0004085_abnormal_heartbeat | 0.40172116 |
| 106 | MP0005083_abnormal_biliary_tract | 0.39944609 |
| 107 | MP0004197_abnormal_fetal_growth/weight/ | 0.38440753 |
| 108 | MP0000343_altered_response_to | 0.38132225 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.37925592 |
| 110 | MP0005275_abnormal_skin_tensile | 0.36968813 |
| 111 | MP0003191_abnormal_cellular_cholesterol | 0.34660915 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.34204074 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31698442 |
| 114 | MP0001849_ear_inflammation | 0.29865338 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.29816984 |
| 116 | MP0003948_abnormal_gas_homeostasis | 0.28785883 |
| 117 | MP0001943_abnormal_respiration | 0.28082052 |
| 118 | MP0008770_decreased_survivor_rate | 0.27477339 |
| 119 | MP0003385_abnormal_body_wall | 0.27127568 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.26858363 |
| 121 | MP0004859_abnormal_synaptic_plasticity | 0.26327933 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.25860842 |
| 123 | MP0003755_abnormal_palate_morphology | 0.25649017 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.25232123 |
| 125 | MP0004510_myositis | 0.24665945 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.22806924 |
| 127 | MP0002932_abnormal_joint_morphology | 0.21903915 |
| 128 | MP0002066_abnormal_motor_capabilities/c | 0.21861964 |
| 129 | MP0002128_abnormal_blood_circulation | 0.21134159 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.18789412 |
| 131 | MP0001730_embryonic_growth_arrest | 0.18361200 |
| 132 | MP0002734_abnormal_mechanical_nocicepti | 0.17721663 |
| 133 | MP0003045_fibrosis | 0.16989830 |
| 134 | MP0009115_abnormal_fat_cell | 0.16563001 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.15931054 |
| 136 | MP0003956_abnormal_body_size | 0.14939413 |
| 137 | MP0002081_perinatal_lethality | 0.14739944 |
| 138 | MP0002925_abnormal_cardiovascular_devel | 0.14370349 |
| 139 | MP0003941_abnormal_skin_development | 0.14069520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 9.78419749 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 9.77345973 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.39539787 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 8.97642702 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 8.97642702 |
| 6 | Nemaline bodies (HP:0003798) | 8.84066228 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 8.60689073 |
| 8 | Absent/shortened dynein arms (HP:0200106) | 8.45596774 |
| 9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 8.45596774 |
| 10 | Exercise-induced myalgia (HP:0003738) | 8.39961626 |
| 11 | Abnormal ciliary motility (HP:0012262) | 8.35332124 |
| 12 | Rhinitis (HP:0012384) | 7.89765512 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 7.83440791 |
| 14 | Distal arthrogryposis (HP:0005684) | 7.45892727 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 7.23330206 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.01070777 |
| 17 | Round ear (HP:0100830) | 6.53452941 |
| 18 | Myopathic facies (HP:0002058) | 6.50852708 |
| 19 | Chronic bronchitis (HP:0004469) | 6.30411947 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 6.26503112 |
| 21 | Ulnar deviation of the wrist (HP:0003049) | 6.25812164 |
| 22 | Bronchiectasis (HP:0002110) | 5.85088030 |
| 23 | Nasal polyposis (HP:0100582) | 5.54587385 |
| 24 | Difficulty running (HP:0009046) | 5.51665817 |
| 25 | Calcaneovalgus deformity (HP:0001848) | 5.47445068 |
| 26 | Muscle fiber splitting (HP:0003555) | 5.20706188 |
| 27 | Myoglobinuria (HP:0002913) | 5.06217309 |
| 28 | Absent phalangeal crease (HP:0006109) | 5.04122706 |
| 29 | Deformed tarsal bones (HP:0008119) | 4.95013888 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 4.68839429 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 4.65427577 |
| 32 | Muscle stiffness (HP:0003552) | 4.61478811 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 4.53616475 |
| 34 | Rhabdomyolysis (HP:0003201) | 4.30120150 |
| 35 | Abnormality of the calf musculature (HP:0001430) | 4.27437560 |
| 36 | Abnormal finger flexion creases (HP:0006143) | 4.21341440 |
| 37 | Increased connective tissue (HP:0009025) | 4.17740502 |
| 38 | Myotonia (HP:0002486) | 4.08664001 |
| 39 | Malignant hyperthermia (HP:0002047) | 3.81805986 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.78920509 |
| 41 | Subaortic stenosis (HP:0001682) | 3.78920509 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.64331860 |
| 43 | Difficulty climbing stairs (HP:0003551) | 3.59305950 |
| 44 | Infertility (HP:0000789) | 3.47116908 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.45536810 |
| 46 | Shoulder girdle muscle weakness (HP:0003547) | 3.43698569 |
| 47 | Neck muscle weakness (HP:0000467) | 3.41332583 |
| 48 | Abnormality of the calcaneus (HP:0008364) | 3.37834961 |
| 49 | Pelvic girdle muscle weakness (HP:0003749) | 3.33116734 |
| 50 | Bronchitis (HP:0012387) | 3.27961186 |
| 51 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.21947083 |
| 52 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.21947083 |
| 53 | Increased variability in muscle fiber diameter (HP:0003557) | 3.21822515 |
| 54 | Recurrent sinusitis (HP:0011108) | 3.18644035 |
| 55 | Areflexia of lower limbs (HP:0002522) | 3.11173182 |
| 56 | Male infertility (HP:0003251) | 3.10288436 |
| 57 | Chronic sinusitis (HP:0011109) | 3.09515624 |
| 58 | Frequent falls (HP:0002359) | 3.01558181 |
| 59 | Recurrent otitis media (HP:0000403) | 2.92954856 |
| 60 | Sudden death (HP:0001699) | 2.88786385 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.86895554 |
| 62 | Hyperkalemia (HP:0002153) | 2.73297078 |
| 63 | Abnormality of the neuromuscular junction (HP:0003398) | 2.71033194 |
| 64 | Fatigable weakness (HP:0003473) | 2.71033194 |
| 65 | Atelectasis (HP:0100750) | 2.67944885 |
| 66 | EMG: neuropathic changes (HP:0003445) | 2.59862279 |
| 67 | Slender build (HP:0001533) | 2.55958997 |
| 68 | Hyperactive renin-angiotensin system (HP:0000841) | 2.54757633 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.53146342 |
| 70 | Occipital encephalocele (HP:0002085) | 2.44963500 |
| 71 | Paralysis (HP:0003470) | 2.43039104 |
| 72 | Hypoplastic ischia (HP:0003175) | 2.33954761 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.33891226 |
| 74 | Bulbar palsy (HP:0001283) | 2.33257550 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.32554939 |
| 76 | Muscular dystrophy (HP:0003560) | 2.32104480 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.31147133 |
| 78 | Limb-girdle muscle weakness (HP:0003325) | 2.29982977 |
| 79 | Proximal amyotrophy (HP:0007126) | 2.26728027 |
| 80 | Gowers sign (HP:0003391) | 2.22393145 |
| 81 | Chronic otitis media (HP:0000389) | 2.17522891 |
| 82 | Popliteal pterygium (HP:0009756) | 2.16145393 |
| 83 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.15478024 |
| 84 | Nonprogressive disorder (HP:0003680) | 2.14443101 |
| 85 | Weak cry (HP:0001612) | 2.13423285 |
| 86 | Metatarsus adductus (HP:0001840) | 2.10862329 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10201994 |
| 88 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.08951876 |
| 89 | Progressive muscle weakness (HP:0003323) | 2.06687174 |
| 90 | Ulnar deviation of finger (HP:0009465) | 2.05896642 |
| 91 | Pancreatic fibrosis (HP:0100732) | 2.05434195 |
| 92 | Abnormality of the ischium (HP:0003174) | 2.03290830 |
| 93 | Scapular winging (HP:0003691) | 2.00000784 |
| 94 | Facial diplegia (HP:0001349) | 1.98244561 |
| 95 | True hermaphroditism (HP:0010459) | 1.96902630 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 1.95727489 |
| 97 | Spinal rigidity (HP:0003306) | 1.93609555 |
| 98 | Bell-shaped thorax (HP:0001591) | 1.92896279 |
| 99 | Limb-girdle muscle atrophy (HP:0003797) | 1.92650532 |
| 100 | Hip contracture (HP:0003273) | 1.88999369 |
| 101 | Ventricular tachycardia (HP:0004756) | 1.85338465 |
| 102 | Increased density of long bones (HP:0006392) | 1.80907477 |
| 103 | Waddling gait (HP:0002515) | 1.74955039 |
| 104 | Achilles tendon contracture (HP:0001771) | 1.74721638 |
| 105 | Cystic liver disease (HP:0006706) | 1.70971372 |
| 106 | Bundle branch block (HP:0011710) | 1.69329888 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 1.65647979 |
| 108 | Molar tooth sign on MRI (HP:0002419) | 1.65647979 |
| 109 | Nephronophthisis (HP:0000090) | 1.63925737 |
| 110 | Tarsal synostosis (HP:0008368) | 1.61666689 |
| 111 | Type 2 muscle fiber atrophy (HP:0003554) | 1.61519764 |
| 112 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.60899187 |
| 113 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.60184753 |
| 114 | Short palpebral fissure (HP:0012745) | 1.58563035 |
| 115 | Abnormality of the Achilles tendon (HP:0005109) | 1.56918496 |
| 116 | Lipoatrophy (HP:0100578) | 1.55453414 |
| 117 | Long clavicles (HP:0000890) | 1.54240736 |
| 118 | Adducted thumb (HP:0001181) | 1.51793687 |
| 119 | Muscle fiber atrophy (HP:0100295) | 1.50075491 |
| 120 | Dilated cardiomyopathy (HP:0001644) | 1.47697860 |
| 121 | Exercise intolerance (HP:0003546) | 1.47445262 |
| 122 | Congenital hip dislocation (HP:0001374) | 1.46725707 |
| 123 | Hyperuricemia (HP:0002149) | 1.46712760 |
| 124 | Increased purine levels (HP:0004368) | 1.46712760 |
| 125 | Cholelithiasis (HP:0001081) | 1.46638194 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.46554011 |
| 127 | Synostosis involving bones of the feet (HP:0009140) | 1.46086496 |
| 128 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.46086496 |
| 129 | Postaxial foot polydactyly (HP:0001830) | 1.44075652 |
| 130 | Pancreatic cysts (HP:0001737) | 1.43906025 |
| 131 | Aplasia of the musculature (HP:0100854) | 1.43626809 |
| 132 | Renal salt wasting (HP:0000127) | 1.41654443 |
| 133 | Stridor (HP:0010307) | 1.41074668 |
| 134 | Hyponatremia (HP:0002902) | 1.40254289 |
| 135 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.39156513 |
| 136 | Congenital hepatic fibrosis (HP:0002612) | 1.39007289 |
| 137 | Wrist flexion contracture (HP:0001239) | 1.37546413 |
| 138 | Decreased circulating renin level (HP:0003351) | 1.36610306 |
| 139 | Asplenia (HP:0001746) | 1.36145131 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 1.36142838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.45581169 |
| 2 | MAPK15 | 6.55164165 |
| 3 | TTN | 6.40252366 |
| 4 | PHKG2 | 5.47588909 |
| 5 | PHKG1 | 5.47588909 |
| 6 | NME1 | 4.37232511 |
| 7 | EPHA2 | 3.70243951 |
| 8 | PIK3CG | 3.55281577 |
| 9 | NEK1 | 2.97667760 |
| 10 | MAP2K3 | 2.84891776 |
| 11 | MST4 | 2.68428209 |
| 12 | PINK1 | 2.17271248 |
| 13 | PDK4 | 2.10330671 |
| 14 | PDK3 | 2.10330671 |
| 15 | MAP3K7 | 2.09707480 |
| 16 | DMPK | 1.80972770 |
| 17 | TRIB3 | 1.80069606 |
| 18 | MAP2K4 | 1.70807450 |
| 19 | MAPK12 | 1.68199526 |
| 20 | BCKDK | 1.60364094 |
| 21 | SMG1 | 1.58880471 |
| 22 | PIK3CA | 1.51710570 |
| 23 | MUSK | 1.47787416 |
| 24 | MAP2K6 | 1.40492598 |
| 25 | PDK2 | 1.39330873 |
| 26 | PKN2 | 1.06813582 |
| 27 | MST1R | 1.04771210 |
| 28 | ERBB3 | 0.94979112 |
| 29 | MARK2 | 0.94251713 |
| 30 | MAPKAPK3 | 0.84082984 |
| 31 | CSK | 0.83430544 |
| 32 | PRKAA1 | 0.83127713 |
| 33 | PRKAA2 | 0.82347873 |
| 34 | STK24 | 0.79604807 |
| 35 | MAP3K2 | 0.78778251 |
| 36 | TBK1 | 0.78047936 |
| 37 | NEK9 | 0.69828306 |
| 38 | AKT2 | 0.68571130 |
| 39 | ZAK | 0.64690210 |
| 40 | TAOK2 | 0.63598321 |
| 41 | MOS | 0.61722988 |
| 42 | MAP3K13 | 0.61104605 |
| 43 | MAP3K3 | 0.60816262 |
| 44 | LATS2 | 0.59742139 |
| 45 | TESK1 | 0.58651851 |
| 46 | NEK6 | 0.56377861 |
| 47 | ILK | 0.55514245 |
| 48 | TRPM7 | 0.55212739 |
| 49 | MAP3K12 | 0.54901739 |
| 50 | MAPK11 | 0.54098965 |
| 51 | STK16 | 0.54043411 |
| 52 | PNCK | 0.51885911 |
| 53 | STK38 | 0.50316219 |
| 54 | CAMK2G | 0.49293846 |
| 55 | KSR2 | 0.45807979 |
| 56 | STK10 | 0.45754703 |
| 57 | TTK | 0.44995925 |
| 58 | LIMK1 | 0.42324817 |
| 59 | MAP3K10 | 0.40903559 |
| 60 | ARAF | 0.39365962 |
| 61 | HIPK2 | 0.38995130 |
| 62 | MAP3K11 | 0.38091555 |
| 63 | EEF2K | 0.36849636 |
| 64 | MAP3K5 | 0.34574023 |
| 65 | TAOK1 | 0.34144795 |
| 66 | PRKACB | 0.32955946 |
| 67 | PRKCI | 0.32924886 |
| 68 | PTK6 | 0.32751163 |
| 69 | CDK19 | 0.32737606 |
| 70 | MAP3K6 | 0.32716053 |
| 71 | SGK1 | 0.32429838 |
| 72 | MAPK7 | 0.29485273 |
| 73 | RPS6KA3 | 0.27879572 |
| 74 | ZAP70 | 0.27332070 |
| 75 | MAP2K1 | 0.27090142 |
| 76 | EPHA3 | 0.26619635 |
| 77 | SGK3 | 0.26325575 |
| 78 | KSR1 | 0.25044320 |
| 79 | ERN1 | 0.24828103 |
| 80 | MET | 0.24296354 |
| 81 | PRKG1 | 0.24285007 |
| 82 | PAK6 | 0.24028665 |
| 83 | CCNB1 | 0.23681071 |
| 84 | CAMK4 | 0.23128739 |
| 85 | MAP3K9 | 0.21867228 |
| 86 | FLT3 | 0.21316371 |
| 87 | CDC42BPA | 0.20968400 |
| 88 | PKN1 | 0.18879061 |
| 89 | ROCK1 | 0.18386749 |
| 90 | RIPK1 | 0.18203781 |
| 91 | MAP2K2 | 0.17981982 |
| 92 | PRKCQ | 0.17858843 |
| 93 | MAP3K4 | 0.17841314 |
| 94 | PRKACA | 0.17772316 |
| 95 | CAMK2B | 0.17109561 |
| 96 | LATS1 | 0.16347924 |
| 97 | SIK1 | 0.14653529 |
| 98 | RPS6KB1 | 0.14491901 |
| 99 | TIE1 | 0.14449322 |
| 100 | EPHB1 | 0.14381746 |
| 101 | MTOR | 0.14274479 |
| 102 | PAK1 | 0.14135399 |
| 103 | RPS6KB2 | 0.13942476 |
| 104 | ICK | 0.13617343 |
| 105 | RPS6KA2 | 0.13253427 |
| 106 | CAMK1G | 0.12505867 |
| 107 | PDK1 | 0.11145495 |
| 108 | PTK2 | 0.11056059 |
| 109 | MAP3K1 | 0.10909598 |
| 110 | ERBB2 | 0.10903102 |
| 111 | CSNK1D | 0.10692645 |
| 112 | MAPK10 | 0.10638387 |
| 113 | MAPK4 | 0.10208578 |
| 114 | FGFR1 | 0.09385800 |
| 115 | RPS6KA1 | 0.08717516 |
| 116 | PRKD1 | 0.07730284 |
| 117 | LRRK2 | 0.07456064 |
| 118 | ROCK2 | 0.07388038 |
| 119 | PDPK1 | 0.07331814 |
| 120 | PRKDC | 0.07046379 |
| 121 | STK11 | 0.05796525 |
| 122 | CAMK2D | 0.04865223 |
| 123 | RAF1 | 0.04701294 |
| 124 | DYRK1B | 0.03563898 |
| 125 | MAP3K8 | 0.03187639 |
| 126 | PRKACG | 0.02801801 |
| 127 | MAPK8 | 0.02634026 |
| 128 | STK38L | 0.02510889 |
| 129 | BMX | 0.01247849 |
| 130 | CAMK2A | 0.00535014 |
| 131 | MAPK9 | -0.0255501 |
| 132 | CDK12 | -0.0167348 |
| 133 | PTK2B | -0.0115703 |
| 134 | INSRR | -0.0093179 |
| 135 | CSNK1E | -0.0037334 |
| 136 | PAK4 | -0.0022539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.77767777 |
| 2 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.00599221 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.86865050 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.81024060 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 3.76194136 |
| 6 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.60406553 |
| 7 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.32597017 |
| 8 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.30895274 |
| 9 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.25132895 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.06904418 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.82434587 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.70965648 |
| 13 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.52091753 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.44410231 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37691109 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 2.27543539 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27402649 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.25644966 |
| 19 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.22709403 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15515602 |
| 21 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.12428888 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.06641905 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.89519399 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86243488 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.84555885 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.83738604 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.78216731 |
| 28 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.73232560 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.72889700 |
| 30 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72580470 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.68530781 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.61784419 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.52831850 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.52755863 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52412578 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47798036 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40246216 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.31988042 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28235390 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27620079 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24562494 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22573268 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21878421 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19242535 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19017776 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12623557 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10507561 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10367203 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03943062 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03940778 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03729283 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96659520 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.96437847 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93245097 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92293940 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90142063 |
| 57 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89739439 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87475841 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86104700 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.85826753 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.85495451 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82796610 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82774046 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79276805 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78269696 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77250858 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77149123 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74089824 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73329463 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.70737119 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70349352 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.58645831 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54415447 |
| 74 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53697551 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.53507578 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.52984579 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47602416 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47592237 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44783654 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42661957 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.42443662 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39871151 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39206032 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38304219 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36895861 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36509128 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36223392 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35810465 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.34889830 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.33989604 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33518274 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32170149 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.31805318 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31517811 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31115971 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.30652679 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29947544 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29520557 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28893564 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27664221 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27180149 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27103907 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26072074 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.23916679 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23377896 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.21959318 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21792183 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20565760 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.19791405 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18380490 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17927401 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.17684851 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.17137971 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16580619 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.16525222 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14874430 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14662088 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10624911 |
| 119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10533225 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10285303 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.09336019 |
| 122 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.09254919 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.09211953 |
| 124 | RNA degradation_Homo sapiens_hsa03018 | 0.08848044 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.08484818 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08469790 |
| 127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08053258 |
| 128 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.07959803 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07620315 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07578194 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06269044 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.05668896 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.05648053 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.05606385 |
| 135 | Proteasome_Homo sapiens_hsa03050 | 0.04279809 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.02793693 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.02206989 |

